Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

British Journal of Cancer
S DiemJ Larkin

Abstract

Treatment with programmed death receptor-1 (PD-1) antibodies is associated with high response rates in patients with advanced melanoma. Reliable markers for early response and outcome are still sparse. We evaluated 66 consecutive patients with advanced/metastatic melanoma treated with nivolumab or pembrolizumab between 2013 and 2014. The main objectives of this study were to investigate whether, first, serum lactate dehydrogenase (LDH) at baseline (normal vs above the upper limit of normal) correlates with overall survival (OS), and, second, whether the change of LDH during treatment predicts response before the first scan and OS in patients with an elevated baseline LDH. After a median follow-up of 9 months, patients with an elevated baseline LDH (N=34) had a significantly shorter OS compared with patients with normal LDH (N=32; 6-month OS: 60.8% vs 81.6% and 12-month OS: 44.2% vs 71.5% (log-rank P=0.0292). In those 34 patients with elevated baseline LDH, the relative change during treatment was significantly associated with an objective response on the first scan: the 11 (32%) patients with partial remission had a mean reduction of -27.3% from elevated baseline LDH. In contrast, patients with progressive disease (N=15) had a ...Continue Reading

References

Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O EtonR S Benjamin
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P B ChapmanJ M Kirkwood
Nov 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ManolaJ Kirkwood
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
May 8, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sanjiv S AgarwalaAlexander M M Eggermont
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Sep 30, 2014·The New England Journal of Medicine·Georgina V LongKeith Flaherty
Sep 30, 2014·The New England Journal of Medicine·James LarkinAntoni Ribas
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Nov 26, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefan DiemJames Larkin

❮ Previous
Next ❯

Citations

Oct 26, 2016·Expert Review of Anticancer Therapy·Pol Specenier
May 25, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie L GoffSteven A Rosenberg
Mar 8, 2017·Seminars in Cancer Biology·Veronica HuberLicia Rivoltini
Mar 23, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J H LeeH Rizos
Mar 23, 2017·Expert Opinion on Biological Therapy·Pol Specenier
Mar 16, 2017·The Journal of Dermatology·Hajime MiyazawaHiroshi Shimizu
Jun 28, 2017·Nature Reviews. Clinical Oncology·Mizuki NishinoF Stephen Hodi
Jun 13, 2017·Expert Review of Anticancer Therapy·Aine O'reilly, James Larkin
Oct 6, 2017·Breast Cancer : Basic and Clinical Research·Ivan J Cohen, Ronald Blasberg
Aug 26, 2018·The Journal of Dermatology·Toshikazu OmodakaRyuhei Okuyama
Apr 27, 2019·Expert Opinion on Pharmacotherapy·Robert MasonJames Larkin
Aug 25, 2019·Cancers·Yoshitaro ShindoHiroaki Nagano
Aug 31, 2019·Expert Review of Molecular Diagnostics·Ernest Y Lee, Rajan P Kulkarni
Feb 23, 2019·Journal for Immunotherapy of Cancer·Mirjam FässlerLukas Flatz
Jan 19, 2020·International Journal of Molecular Sciences·Sanna Iivanainen, Jussi P Koivunen
Feb 15, 2020·Cells·Celeste LorussoStefania Tommasi
Apr 3, 2020·Journal for Immunotherapy of Cancer·Luca MazzarellaGiuseppe Curigliano
Dec 19, 2017·Journal of Immunotherapy·C Lance CoweyScot W Ebbinghaus
May 14, 2020·Expert Opinion on Investigational Drugs·Laura Amanda BoosJames Larkin
May 27, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·I KrakowskiH Eriksson
Jun 20, 2020·International Journal of Cancer. Journal International Du Cancer·Michiel C T van ZeijlMichel W J M Wouters
Dec 6, 2019·Current Medicinal Chemistry·Martina StrudelPaolo A Ascierto
Aug 18, 2020·Journal of Immunotherapy·Michiel C T van ZeijlAlfons J M van den Eertwegh
Apr 7, 2017·International Journal of Clinical Oncology·Takeshi YuasaJunji Yonese
Aug 15, 2019·Advances in Therapy·Sanjeevani AroraYanis Boumber
Nov 30, 2019·The Journal of Dermatology·Yasuhiro NakamuraMakoto Sugaya
Mar 12, 2020·Oncoimmunology·Sandra Van WilpeNiven Mehra

❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.